Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
1.800
-0.040 (-2.17%)
At close: Dec 5, 2025, 4:00 PM EST
1.810
+0.010 (0.56%)
After-hours: Dec 5, 2025, 7:42 PM EST
Nkarta Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
157
Market Cap
127.85M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
NKTX News
- 4 days ago - Nkarta to Participate in Evercore Healthcare Conference - GlobeNewsWire
- 14 days ago - Nkarta: Pushing Deeper And Deeper Into A Discount Vs. Their Holdings, For No Real Reason - Seeking Alpha
- 26 days ago - Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 5 weeks ago - Nkarta to Participate in November Investor Conferences - GlobeNewsWire
- 6 weeks ago - Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting - GlobeNewsWire
- 3 months ago - Nkarta to Participate in a September Investor Conference - GlobeNewsWire
- 4 months ago - Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 4 months ago - Nkarta to Participate in the H.C. Wainwright “HCW@Home” Series - GlobeNewsWire